Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-03-25
2000-04-04
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 14, 514 15, 514 16, 514 17, 514 18, 530326, 530327, 530328, 530329, 530330, 562443, A61K 3807, A61K 3808, A61K 3810, C07C22932, C07K 708
Patent
active
060461675
ABSTRACT:
The invention provides analogs of PYY. The invention also provides compositions and methods useful for controlling biological activities such as cell proliferation, nutrient transport, lipolysis, and intestinal water and electrolyte secretion.
REFERENCES:
patent: 4871550 (1989-10-01), Millman
patent: 5376640 (1994-12-01), Miyazaki et al.
patent: 5397803 (1995-03-01), Smith et al.
patent: 5574010 (1996-11-01), McFadden
patent: 5604203 (1997-02-01), Balasubramaniam
patent: 5670482 (1997-09-01), Daniels et al.
patent: 5830434 (1998-11-01), Taylor et al.
patent: 5885958 (1999-03-01), Zadina et al.
Balasubramaniam et al. High yield synthesis of pseudopeptide . . . Leiden: ESCOM Science Publ. Peptides: Chemistry, Structure and Biol. pp. 553-555, 1994.
Chemical Abstract: 70: 37018h, 1969.
Galuez et al. Cobalt-Mediated Alkylation . . . Tet. Lett. vol. 37, No. 34, pp. 6197-6200, 1996.
Roberts et al, Basic Principles of Organic Chemistry, 2nd ed. Menlo Park: W.A. Benjamin, Inc, pp. 1208-1210, 1977.
Balasubramaniam, A., et al., Neuropeptides (1989) 14, 209-212.
Laburthe, M., et al., Endocrinology, vol. 118, No. 5, pp. 1910-1917. (1986).
Tatemoto, K., Proc. Natl. Acad. Sci. USA, vol. 79, pp. 2514-2518, Apr. 1982.
Tatemoto, K., Proc. Natl. Acad. Sci. USA, vol. 79, pp. 5485-5489, Sep. 1982.
Ekblad, E., Neuroscience, vol. 20, No. 1, pp. 169-188, 1987.
Laburthe, M., Trends Endocrinol. Metab., vol. 1, No. 3, pp. 168-174, 1990.
Cox, H.M., et al., Br. J. Pharmacol. 101, pp. 247-252, 1990.
Cox, H.M., et al. J. of Physiology, 1988, vol. 398, pp. 65-80.
Cox, H.M., et al., Peptides, vol. 12, pp. 323-327, 1991.
Friel, D.D., et al., Br. J. Pharmacol. (1986), vol. 88, pp. 425-431.
Lundberg, J.M., et al., Proc. Natl. Acad. Sci. USA, vol. 79, pp. 4471-4475, Jul. 1982.
Playford, R.J., et al., The Lancet, 1990; 335: 1555-1557.
MacFadyen, R.J., et al., Neuropeptides 7: 219-227, 1986.
Adrian, T.E., et al., Gastroenterology, 1985; 89: 1070-1077.
Servin, A.L., et al., Endocrinology, vol. 124, No. 2, pp. 692-700. (1989).
Bilchik, A.J., et al., Gastroenterology, vol. 104. No. 4, Part 2, A 236. (1993).
Balasubramaniam, A., et al., Peptide Research, vol. 1, No. 1, 1988, pp. 32-35.
Voisin, T., et al., J. of Biol. Chem., vol. 268, No. 27, Sep. 25, pp. 20547-20554, 1993.
Valet, P., et al., J. Clin. Invest., vol. 85, Jan. 1990, pp. 291-295.
Russel Jeffrey E.
University of Cincinnati
LandOfFree
Peptide YY analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide YY analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide YY analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-365080